Literature DB >> 18377822

Clinical implications of caveolins in malignancy and their potential as therapeutic targets.

Ila Tamaskar1, Ming Zhou.   

Abstract

Caveolae are cell membrane invaginations that were first described in the early 1950s. Since then, researchers have undertaken numerous studies to define their role in normal physiology and disease. The caveolin proteins, particularly caveolin-1, are the major structural and functional components of caveolae, which are involved in a plethora of cellular functions. This review briefly describes the role of caveolae and caveolin proteins in these cellular processes and in different types of human cancers. In addition, it also discusses the use of caveolin-1 as a potential diagnostic and prognostic marker and therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18377822     DOI: 10.1007/s11912-008-0017-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  62 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo.

Authors:  J E Schnitzer
Journal:  Adv Drug Deliv Rev       Date:  2001-07-28       Impact factor: 15.470

3.  Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

Authors:  Tianhong Li; Federica Sotgia; Magalis A Vuolo; Maomi Li; Wan Cai Yang; Richard G Pestell; Joseph A Sparano; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 4.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

5.  Expression profiling of primary non-small cell lung cancer for target identification.

Authors:  Jim Heighway; Teresa Knapp; Lenetta Boyce; Shelley Brennand; John K Field; Daniel C Betticher; Daniel Ratschiller; Mathias Gugger; Michael Donovan; Amy Lasek; Paula Rickert
Journal:  Oncogene       Date:  2002-10-31       Impact factor: 9.867

6.  A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.

Authors:  Yuriko Mori; Kun Cai; Yulan Cheng; Suna Wang; Bogdan Paun; James P Hamilton; Zhe Jin; Fumiaki Sato; Agnes T Berki; Takatsugu Kan; Tetsuo Ito; Carmit Mantzur; John M Abraham; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

7.  Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.

Authors:  B Razani; Y Altschuler; L Zhu; R G Pestell; K E Mostov; M P Lisanti
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

8.  Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide.

Authors:  Agnès Brouet; Julie DeWever; Philippe Martinive; Xavier Havaux; Caroline Bouzin; Pierre Sonveaux; Olivier Feron
Journal:  FASEB J       Date:  2004-12-28       Impact factor: 5.191

9.  Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.

Authors:  Jean Philippe Gratton; Michelle I Lin; Jun Yu; Erik D Weiss; Zao Li Jiang; Todd A Fairchild; Yasuko Iwakiri; Roberto Groszmann; Kevin P Claffey; Yung Chi Cheng; William C Sessa
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

10.  Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma.

Authors:  M Suzuoki; M Miyamoto; K Kato; K Hiraoka; T Oshikiri; Y Nakakubo; A Fukunaga; T Shichinohe; T Shinohara; T Itoh; S Kondo; H Katoh
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

View more
  1 in total

Review 1.  Caveolae as Potential Hijackable Gates in Cell Communication.

Authors:  Maria Dudãu; Elena Codrici; Cristiana Tanase; Mihaela Gherghiceanu; Ana-Maria Enciu; Mihail E Hinescu
Journal:  Front Cell Dev Biol       Date:  2020-10-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.